216 related articles for article (PubMed ID: 34314415)
1. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth.
Springer LE; Patton JB; Zhan T; Rabson AB; Lin HC; Manser T; Lok JB; Hess JA; Abraham D
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009559. PubMed ID: 34314415
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
4. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
6. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
7. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
9. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
[TBL] [Abstract][Full Text] [Related]
10. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
[TBL] [Abstract][Full Text] [Related]
11. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
Robinson RD; Lindo JF; Neva FA; Gam AA; Vogel P; Terry SI; Cooper ES
J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055
[TBL] [Abstract][Full Text] [Related]
12. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
13. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y
Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366
[TBL] [Abstract][Full Text] [Related]
14. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
15. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
16. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
17. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
18. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
[TBL] [Abstract][Full Text] [Related]
19. [Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis].
Alvarez-Falconí PP; Moncada-Vilela Z; Montero-Navarrete S; Hernandez-García JA
Rev Gastroenterol Peru; 2013; 33(4):348-51. PubMed ID: 24419034
[TBL] [Abstract][Full Text] [Related]
20. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
Freites A
Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
